首页> 外文期刊>Singapore medical journal >Incidence and predictors of respiratory adverse events in children undergoing procedural sedation with intramuscular ketamine in a paediatric emergency department
【24h】

Incidence and predictors of respiratory adverse events in children undergoing procedural sedation with intramuscular ketamine in a paediatric emergency department

机译:在儿科急诊部核心氯胺酮中呼吸不良事件的发病率和预测因子

获取原文
           

摘要

INTRODUCTION:Although ketamine is one of the commonest medications used in procedural sedation of children, to our knowledge, there is currently no published report on predictors of respiratory adverse events during ketamine sedation in Asian children. We aimed to determine the incidence of and factors associated with respiratory adverse events in children undergoing procedural sedation with intramuscular (IM) ketamine in a paediatric emergency department (ED) in Singapore.METHODS:A retrospective analysis was done of all children who underwent procedural sedation with IM ketamine in the paediatric ED between 1 April 2013 and 31 October 2017. Demographics and epidemiological data, including any adverse events and interventions, were extracted electronically from the prospective paediatric sedation database. The site of procedure was determined through reviewing medical records. Descriptive statistics were used for incidence and baseline characteristics. Univariate and multivariate logistic regression analyses were performed to determine significant predictors.RESULTS:Among 5,476 children, 102 (1.9%) developed respiratory adverse events. None required intubation or cardiopulmonary resuscitation. Only one required bag-valve-mask ventilation. The incidence rate was higher in children aged 3 years, at 3.6% compared to 1.0% in older children (odds ratio [OR] 3.524, 95% confidence interval [CI] 2.354-5.276; p 0.001). Higher initial ketamine dose (adjusted OR 2.061, 95% CI 1.371-3.100; p = 0.001) and type of procedure (adjusted OR 0.190 (95% CI 0.038-0.953; p = 0.044) were significant independent predictors.CONCLUSION:The overall incidence of respiratory adverse events was 1.9%. Age, initial dose of IM ketamine and type of procedure were significant predictors.
机译:介绍:虽然氯胺酮是儿童的程序镇静中最常见的药物之一,但我们的知识,目前没有关于亚洲儿童氯胺酮镇静期间呼吸不良事件预测因子的公布报告。我们旨在确定与新加坡小儿急诊部(ED)在儿科急诊部(ED)中进行程序镇静的儿童呼吸不良事件相关的发病率和因素。方法:回顾性分析是处理程序镇静的所有儿童在2013年4月1日至2017年10月1日至10月31日的儿科委员会中,从前瞻性小儿镇静数据库以电子方式提取人口统计和流行病学数据,包括任何不良事件和干预措施。通过审查医疗记录确定程序现场。描述性统计用于发病和基线特征。进行单变量和多变量逻辑回归分析以确定重要的预测因子。结果:5,476名儿童,102(1.9%)发育呼吸不良事件。没有必需的插管或心肺复苏。只有一个必需的袋阀掩模通风。 3岁儿童的发病率较高,比年龄较大的儿童为3.6%(少数百分之百(差距[或] 3.524,95%置信区间[CI] 2.354-5.276; P <0.001)。更高的初始氯胺酮剂量(调节或2.061,95%CI 1.371-3.100; P = 0.001)和程序类型(调节或0.190(95%CI 0.038-0.953; P = 0.044)是显着的独立预测因子。结论:总发病率呼吸不良事件为1.9%。年龄,IM氯胺酮的初始剂量和程序类型是显着的预测因子。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号